Study Details
XEN1101 Drug Study for People with Primary Generalized Tonic-Clonic Seizures
(IRB#: IRB_00159508)
The purpose of this research is to learn more about the drug XEN1101 and see if it can help to reduce the frequency of seizures (the number of seizures in a given period of time) in adults with primary generalized tonic-clonic seizures. The University of Utah anticipates enrolling five patients in this study.
- All genders
- Over 18 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- 18-75 years old
- Diagnosed with primary generalized tonic clonic seizures
- must be willing to take contraceptions
- keep an accurate seizure diary
- in person at University of Utah
Exclusion Criteria
- seizure type does not fit correct diagnosis
- History of drug or alcohol abuse
- pregnant
- mental health concerns
- labs out of normal range
Will I be paid for my time?
Yes
IRB#: IRB_00159508
PI: Amir Arain
Department: NEUROLOGY
Approval Date: 2023-08-16 06:00:00
Study Categories: Brain Health Studies
Specialties: Neurology